OTTAWA, Dec. 19, 2014 /CNW/ -
The sexual enhancement product "Herberex" (NPN 80041180) is being recalled nationwide after Health Canada testing confirmed it contains an undeclared drug: tadalafil. The distributor, Empire Health Distribution of Terrebonne, Quebec, is recalling all lots of this product from retail stores across Canada. Promoted as a natural sex enhancer for men and women, this product may pose serious health risks, especially for people with heart problems.
Who is affected:
Consumers who have bought or used Herberex.
What consumers should do
- Consult with your doctor if you have used this product and have health concerns
- Report any adverse events to Health Canada.
What Health Canada is doing:
Health Canada is monitoring the recall. Should additional products or issues be identified, Health Canada will take appropriate action and inform Canadians.
Tadalafil should only be used under the supervision of a healthcare practitioner. Products containing tadalafil or its analogs (very similar substances) should never be used by individuals taking any kind of nitrate drug (e.g. nitroglycerine) as it can cause potentially life-threatening low blood pressure.
Individuals with heart problems including high blood pressure, a history of heart attack, stroke, abnormal heart beat or chest pain are at higher risk of cardiovascular side-effects if they engage in sexual activity. Other possible side-effects of using tadalafil include headache, facial flushing, indigestion, dizziness, abnormal vision and hearing loss.
Health Canada has not received any reports of adverse reactions involving Herberex.
Herberex (NPN 80041180)
How to report side effects to health products to Health Canada:
- Call toll-free at 1-866-234-2345
- Visit MedEffect Canada's web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
Herberex – bottle of 10 capsules (bottle front and ingredients list)
Également disponible en français
SOURCE: Health Canada
For further information: Media Enquiries: Health Canada, (613) 957-2983; Public Enquiries: (613) 957-2991, 1-866 225-0709